Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lixte Biotechnology Holdings Inc. Warrant (LIXTW:NASDAQ), powered by AI.
Lixte Biotechnology Holdings Inc. Warrant is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lixte Biotechnology Holdings Inc. Warrant on Alpha Lenz.
View Lixte Biotechnology Holdings Inc. Warrant's valuation metrics on Alpha Lenz.
“Lixte Biotechnology Holdings Inc. Warrant's ROE is -148.7%. Explore profitability and growth together.”
Ask for details →Lixte Biotechnology Holdings Inc. Warrant represents a financial derivative tied to Lixte Biotechnology Holdings Inc., a company engaged in the biotechnology sector, specifically focused on developing treatments for human cancers and other serious common diseases. The primary function of this warrant is to provide the holder with the right, but not the obligation, to purchase shares of Lixte Biotechnology common stock at a specified price before an expiration date. Such warrants are typically issued with the intent to attract investment, offering potential upside benefits if the company's stock price appreciates. Notable features of the Lixte Biotechnology Holdings Inc. Warrant include its leverage on the underlying stock, giving investors a way to gain exposure to the innovative developments in cancer treatment and biotechnology without needing to purchase shares outright. In the financial market, warrants like this serve as a tool for companies to raise capital and for investors to participate in the growth potential of emerging and cutting-edge sectors.
“Lixte Biotechnology Holdings Inc. Warrant's ROE is -148.7%. Explore profitability and growth together.”
Ask for details →Lixte Biotechnology Holdings Inc. Warrant (ticker: LIXTW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 2 employees.
The current price is $0.022 with a P/E ratio of -x and P/B of -x.
ROE is -148.73%.